Royal Bank of Canada’s Molecular Partners MOLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,500
Closed -$6K 7354
2024
Q1
$6K Buy
+1,500
New +$6.61K ﹤0.01% 6389
2023
Q1
Sell
-300
Closed -$2K 7321
2022
Q4
$2K Hold
300
﹤0.01% 6939
2022
Q3
$2K Hold
300
﹤0.01% 7040
2022
Q2
$2K Hold
300
﹤0.01% 6971
2022
Q1
$6K Buy
+300
New +$7.28K ﹤0.01% 7184

Other funds holding MOLN

Royal Bank of Canada's MOLN Position: Q2 2024 in Review

Royal Bank of Canada sold out of Molecular Partners (MOLN) in Q2 2024, closing a stake of 1,500 shares — an estimated $6K sold.

Royal Bank of Canada first reported a position in MOLN in Q1 2022 and held it in 5 quarters. The position peaked at $6K in Q1 2024. 8 funds tracked by Wall St. Rank hold MOLN as of Q2 2024.

  • Royal Bank of Canada reported no remaining Molecular Partners position as of Q2 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 1,500 Molecular Partners shares in Q2 2024, an estimated $6K.
  • Royal Bank of Canada first reported a position in Molecular Partners in Q1 2022 and held it in 5 quarters.
  • Royal Bank of Canada's Molecular Partners position peaked at $6K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Molecular Partners as of Q2 2024.

Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.